Novel Treatment of Intermittent Claudication in Patients With Peripheral Arterial Disease Using Danshen Gegen (D&G) Capsule
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 107 participants.
Also called NCT02380794
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 107 participants
- Registry
-
NCT02380794
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Hong Kong SAR China
- Registry status
- Completed
Technical summary
Registry record NCT02380794. Randomized; triple masking; primary purpose treatment. Start 2015-10-28 (actual); primary completion 2017-06-02 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Novel Treatment of Intermittent Claudication in Patients With Peripheral Arterial Disease Using Danshen Gegen (D&G) Capsule
- Condition
- Peripheral Arterial Disease
- Condition
- Intermittent Claudication
- Intervention (Drug)
- Danshen Gegen Capsule
- Intervention (Drug)
- Placebo
- Lead sponsor
- Chinese University of Hong Kong
Record details
- Record id
cardio:ct-nct02380794- Content hash
fd3f624067b0b83dddf5cfab35d5eae75932b3020f84f975fcc9688612de5b4c